药品注册申请号:018948
申请类型:NDA (新药申请)
申请人:LEADIANT BIOSCI INC
申请人全名:LEADIANT BIOSCIENCES INC
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 CARNITOR LEVOCARNITINE TABLET;ORAL 330MG Yes Yes AB 1985/12/27 1985/12/27 Prescription
002 CARNITOR LEVOCARNITINE SOLUTION;ORAL 1GM/10ML No No None 1988/04/27 Discontinued
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2018/04/17 SUPPL-28(补充) Approval Labeling STANDARD ;Orphan
2015/05/29 SUPPL-26(补充) Approval Labeling STANDARD
2013/02/22 SUPPL-25(补充) Approval Manufacturing (CMC) PRIORITY
2007/03/28 SUPPL-24(补充) Approval Labeling STANDARD
2002/04/15 SUPPL-22(补充) Approval Labeling STANDARD
1998/12/15 SUPPL-21(补充) Approval Labeling STANDARD
1997/10/21 SUPPL-20(补充) Approval Manufacturing (CMC) PRIORITY
1997/01/27 SUPPL-19(补充) Approval Manufacturing (CMC) PRIORITY
1996/04/16 SUPPL-18(补充) Approval Manufacturing (CMC) PRIORITY
1995/12/20 SUPPL-17(补充) Approval Manufacturing (CMC) PRIORITY
1994/04/13 SUPPL-12(补充) Approval Manufacturing (CMC) PRIORITY
1993/05/11 SUPPL-11(补充) Approval Manufacturing (CMC) PRIORITY
1992/12/16 SUPPL-9(补充) Approval Efficacy
1992/07/22 SUPPL-15(补充) Approval Labeling
1992/07/14 SUPPL-16(补充) Approval Labeling
1992/04/14 SUPPL-13(补充) Approval Manufacturing (CMC) PRIORITY
1992/02/21 SUPPL-10(补充) Approval Labeling
1989/12/07 SUPPL-8(补充) Approval Manufacturing (CMC) PRIORITY
1989/12/07 SUPPL-7(补充) Approval Manufacturing (CMC) PRIORITY
1989/03/22 SUPPL-6(补充) Approval Manufacturing (CMC) PRIORITY
1988/09/16 SUPPL-5(补充) Approval Labeling
1988/04/27 SUPPL-4(补充) Approval Manufacturing (CMC) PRIORITY
1985/12/27 ORIG-1(原始申请) Approval Type 1 - New Molecular Entity PRIORITY ;Orphan
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:LEVOCARNITINE 剂型/给药途径:TABLET;ORAL 规格:330MG 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
018948 001 NDA CARNITOR LEVOCARNITINE TABLET;ORAL 330MG Prescription Yes Yes AB 1985/12/27 LEADIANT BIOSCI INC
076858 001 ANDA LEVOCARNITINE LEVOCARNITINE TABLET;ORAL 330MG Prescription No No AB 2004/09/20 RISING
216384 001 ANDA LEVOCARNITINE LEVOCARNITINE TABLET;ORAL 330MG Prescription No No AB 2022/12/09 NOVITIUM PHARMA
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database